REGULATORY
Toxic Epidermal Necrolysis Added to Clinically Significant ADR List for Vectibix
The Ministry of Health, Labor and Welfare issued a pharmaceutical safety information bulletin on September 15, notifying physicians that toxic epidermal necrolysis has been added to the list of clinically significant adverse reactions in the package insert for Takeda Pharmaceutical’s…
To read the full story
Related Article
- MHLW Calls for Package Insert Revision for Inavir, Relenza
August 7, 2015
REGULATORY
- Officer Replacement Orders a “Last Resort” under PMD Act: MHLW Official
September 18, 2026
- Japan Panel Sees No Scientific Objection to Capvaxive NIP Addition
September 18, 2026
- Tavneos Blue Letter Action “Too Slow,” MHLW Panel Member Says
September 18, 2026
- Takaichi Tasks Ueno with Charting Growth Strategy for Drug Innovation
September 18, 2026
- Japan HIV, AIDS Cases Rise in H1 after 2025 Lows
September 18, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





